keyword
https://read.qxmd.com/read/36053684/nonvolatile-electric-field-control-of-thermal-magnons-in-the-absence-of-an-applied-magnetic-field
#21
JOURNAL ARTICLE
Eric Parsonnet, Lucas Caretta, Vikram Nagarajan, Hongrui Zhang, Hossein Taghinejad, Piush Behera, Xiaoxi Huang, Pravin Kavle, Abel Fernandez, Dmitri Nikonov, Hai Li, Ian Young, James Analytis, Ramamoorthy Ramesh
Spin transport through magnetic insulators has been demonstrated in a variety of materials and is an emerging pathway for next-generation spin-based computing. To modulate spin transport in these systems, one typically applies a sufficiently strong magnetic field to allow for deterministic control of magnetic order. Here, we make use of the well-known multiferroic magnetoelectric, BiFeO_{3}, to demonstrate nonvolatile, hysteretic, electric-field control of thermally excited magnon current in the absence of an applied magnetic field...
August 19, 2022: Physical Review Letters
https://read.qxmd.com/read/35973733/sars-cov-2-infection-during-the-omicron-surge-among-patients-receiving-dialysis-the-role-of-circulating-receptor-binding-domain-antibodies-and-vaccine-doses
#22
JOURNAL ARTICLE
Maria E Montez-Rath, Pablo Garcia, Jialin Han, LinaCel Cadden, Patti Hunsader, Curt Morgan, Russell Kerschmann, Paul Beyer, Mary Dittrich, Geoffrey A Block, Julie Parsonnet, Glenn M Chertow, Shuchi Anand
BACKGROUND: It is unclear whether circulating antibody levels conferred protection against SARS-CoV-2 infection among patients receiving dialysis during the Omicron-dominant period. METHODS: We followed monthly semiquantitative SARS-CoV-2 RBD IgG index values in a randomly selected nationwide cohort of patients receiving dialysis and ascertained SARS-CoV-2 infection during the Omicron-dominant period of December 25, 2021 to January 31, 2022 using electronic health records...
August 16, 2022: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/35855959/calscope-monitoring-severe-acute-respiratory-syndrome-coronavirus-2-seroprevalence-from-vaccination-and-prior-infection-in-adults-and-children-in-california-may-2021-july-2021
#23
JOURNAL ARTICLE
Megha L Mehrotra, Esther Lim, Katherine Lamba, Amanda Kamali, Kristina W Lai, Erika Meza, Irvin Szeto, Peter Robinson, Cheng-Ting Tsai, David Gebhart, Noemi Fonseca, Andrew B Martin, Catherine Ley, Steve Scherf, James Watt, David Seftel, Julie Parsonnet, Seema Jain
Background: Understanding the distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies from vaccination and/or prior infection is critical to the public health response to the pandemic. CalScope is a population-based serosurvey in 7 counties in California. Methods: We invited 200 000 randomly sampled households to enroll up to 1 adult and 1 child between April 20, 2021 and June 16, 2021. We tested all specimens for antibodies against SARS-CoV-2 nucleocapsid and spike proteins, and each participant completed an online survey...
July 2022: Open Forum Infectious Diseases
https://read.qxmd.com/read/35618823/enabling-ultra-low-voltage-switching-in-batio-3
#24
JOURNAL ARTICLE
Y Jiang, E Parsonnet, A Qualls, W Zhao, S Susarla, D Pesquera, A Dasgupta, M Acharya, H Zhang, T Gosavi, C-C Lin, D E Nikonov, H Li, I A Young, R Ramesh, L W Martin
Single crystals of BaTiO3 exhibit small switching fields and energies, but thin-film performance is considerably worse, thus precluding their use in next-generation devices. Here, we demonstrate high-quality BaTiO3 thin films with nearly bulk-like properties. Thickness scaling provides access to the coercive voltages (<100 mV) and fields (<10 kV cm-1 ) required for future applications and results in a switching energy of <2 J cm-3 (corresponding to <2 aJ per bit in a 10 × 10 × 10 nm3 device)...
July 2022: Nature Materials
https://read.qxmd.com/read/35588734/tnf-%C3%AE-cd4-t-cells-dominate-the-sars-cov-2-specific-t-cell-response-in-covid-19-outpatients-and-are-associated-with-durable-antibodies
#25
JOURNAL ARTICLE
Kattria van der Ploeg, Adam S Kirosingh, Diego A M Mori, Saborni Chakraborty, Zicheng Hu, Benjamin L Sievers, Karen B Jacobson, Hector Bonilla, Julie Parsonnet, Jason R Andrews, Kathleen D Press, Maureen C Ty, Daniel R Ruiz-Betancourt, Lauren de la Parte, Gene S Tan, Catherine A Blish, Saki Takahashi, Isabel Rodriguez-Barraquer, Bryan Greenhouse, Upinder Singh, Taia T Wang, Prasanna Jagannathan
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific CD4+ T cells are likely important in immunity against coronavirus 2019 (COVID-19), but our understanding of CD4+ longitudinal dynamics following infection and of specific features that correlate with the maintenance of neutralizing antibodies remains limited. Here, we characterize SARS-CoV-2-specific CD4+ T cells in a longitudinal cohort of 109 COVID-19 outpatients enrolled during acute infection. The quality of the SARS-CoV-2-specific CD4+ response shifts from cells producing interferon gamma (IFNγ) to tumor necrosis factor alpha (TNF-α) from 5 days to 4 months post-enrollment, with IFNγ- IL-21- TNF-α+ CD4+ T cells the predominant population detected at later time points...
June 21, 2022: Cell reports medicine
https://read.qxmd.com/read/35586273/applicability-of-the-commonly-used-risk-scores-for-coronary-bypass-surgery-in-algeria
#26
JOURNAL ARTICLE
Abdelkader Boukhmis, Mohamed El-Amin Nouar, Mohamed Karim Guerchani
OBJECTIVES: The applicability of European system for cardiac operative risk evaluation II (EuroSCORE II) and the Society of Thoracic Surgeons Predicted Risk Of Mortality (STS-PROM) as well as the initial logistic Parsonnet risk score, who have been developed from European and American datasets, is questionable outside these regions. We aimed to assess the performance of these three risk scores for patients undergoing isolated coronary artery bypass grafting (CABG) in Algeria. METHODS: Between June 2014 and June 2016, data from 235 consecutive patients, who underwent isolated CABG at a reference center in Algiers, were prospectively collected and scored according to the EuroSCORE II, STS-PROM and the Parsonnet score...
2022: Journal of the Saudi Heart Association
https://read.qxmd.com/read/35446944/favipiravir-for-treatment-of-outpatients-with-asymptomatic-or-uncomplicated-covid-19-a-double-blind-randomized-placebo-controlled-phase-2-trial
#27
JOURNAL ARTICLE
Marisa Holubar, Aruna Subramanian, Natasha Purington, Haley Hedlin, Bryan Bunning, Katharine S Walter, Hector Bonilla, Athanasia Boumis, Michael Chen, Kimberly Clinton, Liisa Dewhurst, Carol Epstein, Prasanna Jagannathan, Richard H Kaszynski, Lori Panu, Julie Parsonnet, Elizabeth L Ponder, Orlando Quintero, Elizabeth Sefton, Upinder Singh, Luke Soberanis, Henry Truong, Jason R Andrews, Manisha Desai, Chaitan Khosla, Yvonne Maldonado
BACKGROUND: Favipiravir is an oral, RNA-dependent RNA polymerase inhibitor with in vitro activity against SARS-CoV2. Despite limited data, favipiravir is administered to patients with COVID-19 in several countries. METHODS: We conducted a phase 2 double-blind randomized controlled outpatient trial of favipiravir in asymptomatic or mildly symptomatic adults with a positive SARS-CoV2 RT-PCR within 72 hours of enrollment. Participants were randomized 1: 1 to receive placebo or favipiravir (1800mg BID Day 1, 800 mg BID Days 2-10)...
April 21, 2022: Clinical Infectious Diseases
https://read.qxmd.com/read/35434682/gastrointestinal-symptoms-and-fecal-shedding-of-sars-cov-2-rna-suggest-prolonged-gastrointestinal-infection
#28
JOURNAL ARTICLE
Aravind Natarajan, Soumaya Zlitni, Erin F Brooks, Summer E Vance, Alex Dahlen, Haley Hedlin, Ryan M Park, Alvin Han, Danica T Schmidtke, Renu Verma, Karen B Jacobson, Julie Parsonnet, Hector F Bonilla, Upinder Singh, Benjamin A Pinsky, Jason R Andrews, Prasanna Jagannathan, Ami S Bhatt
Background: COVID-19 manifests with respiratory, systemic, and gastrointestinal (GI) symptoms.1,2 SARS-CoV-2 RNA is detected in respiratory and fecal samples, and recent reports demonstrate viral replication in both the lung and intestinal tissue.3-5 Although much is known about early fecal RNA shedding, little is known about the long term shedding, especially in those with mild COVID-19. Furthermore, most reports of fecal RNA shedding do not correlate these findings with GI symptoms...
April 13, 2022: Med
https://read.qxmd.com/read/35383042/sars-cov-2-booster-vaccine-response-among-patients-receiving-dialysis
#29
LETTER
Pablo Garcia, Jialin Han, Maria E Montez-Rath, Sumi Sun, Tiffany Shang, Julie Parsonnet, Glenn M Chertow, Shuchi Anand, Brigitte Schiller, Graham Abra
No abstract text is available yet for this article.
July 2022: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/35325084/frequency-and-geographic-distribution-of-borrelia-miyamotoi-borrelia-burgdorferi-and-babesia-microti-infections-in-new-england-residents
#30
JOURNAL ARTICLE
Demerise Johnston, Jill R Kelly, Michel Ledizet, Nathalie Lavoie, Robert P Smith, Jeffrey Parsonnet, Jonathan Schwab, John Stratidis, Scott Espich, Giyoung Lee, Kaitlin R Maciejewski, Yanhong Deng, Victoria Majam, Hong Zheng, Sougr-Nooma Bonkoungou, June Stevens, Sanjai Kumar, Peter J Krause
BACKGROUND: Borrelia miyamotoi is a relapsing fever spirochete that relatively recently has been reported to infect humans. It causes an acute undifferentiated febrile illness that can include meningoencephalitis and relapsing fever. Like Borrelia burgdorferi, it is transmitted by Ixodes scapularis ticks in the northeastern United States and by Ixodes pacificus ticks in the western United States. Despite reports of clinical cases from North America, Europe, and Asia, the prevalence, geographic range, and pattern of expansion of human B...
March 23, 2022: Clinical Infectious Diseases
https://read.qxmd.com/read/35313586/sars-cov-2-infection-during-the-omicron-surge-among-patients-receiving-dialysis-the-role-of-circulating-receptor-binding-domain-antibodies-and-vaccine-doses
#31
Maria E Montez-Rath, Pablo Garcia, Jialin Han, LinaCel Cadden, Patti Hunsader, Curt Morgan, Russell Kerschmann, Paul Beyer, Mary Dittrich, Geoffrey A Block, Shuchi Anand, Julie Parsonnet, Glenn M Chertow
Background: It is unclear whether a third dose of mRNA platform vaccines, or antibody response to prior infection or vaccination confer protection from the Omicron variant among patients receiving dialysis. Methods: Monthly since February 2021, we tested plasma from 4,697 patients receiving dialysis for antibodies to the receptor-binding domain (RBD) of SARS-CoV-2. We assessed semiquantitative median IgG index values over time among patients vaccinated with at least one dose of the two mRNA vaccines...
March 18, 2022: medRxiv
https://read.qxmd.com/read/35139722/modeling-the-patient-mix-for-risk-adjusted-cumulative-sum-charts
#32
JOURNAL ARTICLE
Philipp Wittenberg
The improvement of surgical quality and the corresponding early detection of its changes is of increasing importance. To this end, sequential monitoring procedures such as the risk-adjusted CUmulative SUM chart are frequently applied. The patient risk score population (patient mix), which considers the patients' perioperative risk, is a core component for this type of quality control chart. Consequently, it is important to be able to adapt different shapes of patient mixes and determine their impact on the monitoring scheme...
February 9, 2022: Statistical Methods in Medical Research
https://read.qxmd.com/read/35138890/ferroelectricity-in-a-semiconducting-all-inorganic-halide-perovskite
#33
JOURNAL ARTICLE
Ye Zhang, Eric Parsonnet, Abel Fernandez, Sinéad M Griffin, Huaixun Huyan, Chung-Kuan Lin, Teng Lei, Jianbo Jin, Edward S Barnard, Archana Raja, Piush Behera, Xiaoqing Pan, Ramamoorthy Ramesh, Peidong Yang
Ferroelectric semiconductors are rare materials with both spontaneous polarizations and visible light absorptions that are promising for designing functional photoferroelectrics, such as optical switches and ferroelectric photovoltaics. The emerging halide perovskites with remarkable semiconducting properties also have the potential of being ferroelectric, yet the evidence of robust ferroelectricity in the typical three-dimensional hybrid halide perovskites has been elusive. Here, we report on the investigation of ferroelectricity in all-inorganic halide perovskites, CsGeX3 , with bandgaps of 1...
February 11, 2022: Science Advances
https://read.qxmd.com/read/35132407/early-immune-responses-have-long-term-associations-with-clinical-virologic-and-immunologic-outcomes-in-patients-with-covid-19
#34
Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, Prabhu Arunachalam, Diego Mori, Karen Jacobson, Hector Bonilla, Julie Parsonnet, Jason Andrews, Haley Hedlin, Lauren de la Parte, Kathleen Dantzler, Maureen Ty, Gene Tan, Catherine Blish, Saki Takahashi, Isabel Rodriguez-Barraquer, Bryan Greenhouse, Atul Butte, Upinder Singh, Bali Pulendran, Taia Wang, Prasanna Jagannathan
The great majority of SARS-CoV-2 infections are mild and uncomplicated, but some individuals with initially mild COVID-19 progressively develop more severe symptoms. Furthermore, there is substantial heterogeneity in SARS-CoV-2-specific memory immune responses following infection. There remains a critical need to identify host immune biomarkers predictive of clinical and immunologic outcomes in SARS-CoV-2-infected patients. Leveraging longitudinal samples and data from a clinical trial in SARS-CoV-2 infected outpatients, we used host proteomics and transcriptomics to characterize the trajectory of the immune response in COVID-19 patients within the first 2 weeks of symptom onset...
February 2, 2022: Research Square
https://read.qxmd.com/read/35079772/long-term-accuracy-of-sars-cov-2-interferon-%C3%AE-release-assay-and-its-application-in-household-investigation
#35
JOURNAL ARTICLE
Kanagavel Murugesan, Prasanna Jagannathan, Jonathan Altamirano, Yvonne A Maldonado, Hector F Bonilla, Karen B Jacobson, Julie Parsonnet, Jason R Andrews, Run-Zhang Shi, Scott Boyd, Benjamin A Pinsky, Upinder Singh, Niaz Banaei
BACKGROUND: An immunodiagnostic assay that sensitively detects a cell-mediated immune response to SARS-CoV-2 is needed for epidemiological investigation and for clinical assessment of T cell-mediated immune response to vaccines, particularly in the context of emerging variants that might escape antibody responses. METHODS: The performance of a whole blood interferon-gamma (IFN-γ) release assay (IGRA) for the detection of SARS-CoV-2 antigen-specific T cells was evaluated in COVID-19 convalescents tested serially up to 10 months post-infection and in healthy blood donors...
January 25, 2022: Clinical Infectious Diseases
https://read.qxmd.com/read/35013263/microbial-enzymes-induce-colitis-by-reactivating-triclosan-in-the-mouse-gastrointestinal-tract
#36
JOURNAL ARTICLE
Jianan Zhang, Morgan E Walker, Katherine Z Sanidad, Hongna Zhang, Yanshan Liang, Ermin Zhao, Katherine Chacon-Vargas, Vladimir Yeliseyev, Julie Parsonnet, Thomas D Haggerty, Guangqiang Wang, Joshua B Simpson, Parth B Jariwala, Violet V Beaty, Jun Yang, Haixia Yang, Anand Panigrahy, Lisa M Minter, Daeyoung Kim, John G Gibbons, LinShu Liu, Zhengze Li, Hang Xiao, Valentina Borlandelli, Hermen S Overkleeft, Erica W Cloer, Michael B Major, Dennis Goldfarb, Zongwei Cai, Matthew R Redinbo, Guodong Zhang
Emerging research supports that triclosan (TCS), an antimicrobial agent found in thousands of consumer products, exacerbates colitis and colitis-associated colorectal tumorigenesis in animal models. While the intestinal toxicities of TCS require the presence of gut microbiota, the molecular mechanisms involved have not been defined. Here we show that intestinal commensal microbes mediate metabolic activation of TCS in the colon and drive its gut toxicology. Using a range of in vitro, ex vivo, and in vivo approaches, we identify specific microbial β-glucuronidase (GUS) enzymes involved and pinpoint molecular motifs required to metabolically activate TCS in the gut...
January 10, 2022: Nature Communications
https://read.qxmd.com/read/34974350/inflammatory-but-not-respiratory-symptoms-are-associated-with-ongoing-upper-airway-viral-shedding-in-outpatients-with-uncomplicated-covid-19
#37
JOURNAL ARTICLE
Karen B Jacobson, Natasha Purington, Julie Parsonnet, Jason Andrews, Vidhya Balasubramanian, Hector Bonilla, Karlie Edwards, Manisha Desai, Upinder Singh, Haley Hedlin, Prasanna Jagannathan
Although the vast majority of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections are uncomplicated, our understanding of predictors of symptom resolution and viral shedding cessation remains limited. We characterized symptom trajectories and oropharyngeal viral shedding among 120 outpatients with uncomplicated Coronavirus Disease of 2019 (COVID-19) enrolled in a clinical trial of Peginterferon Lambda, which demonstrated no clinical or virologic benefit compared with placebo. In the combined trial cohort, objective fever was uncommon, inflammatory symptoms (myalgias, fatigue) peaked at 4 to 5 days postsymptom onset, and cough peaked at 9 days...
March 2022: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/34904856/sars-cov-2-vaccine-antibody-response-and-breakthrough-infection-in-patients-receiving-dialysis
#38
JOURNAL ARTICLE
Shuchi Anand, Maria E Montez-Rath, Jialin Han, Pablo Garcia, LinaCel Cadden, Patti Hunsader, Curt Morgan, Russell Kerschmann, Paul Beyer, Mary Dittrich, Geoffrey A Block, Glenn M Chertow, Julie Parsonnet
BACKGROUND: Whether breakthrough SARS-CoV-2 infections after vaccination are related to the level of postvaccine circulating antibody is unclear. OBJECTIVE: To determine longitudinal antibody-based response and risk for breakthrough infection after SARS-CoV-2 vaccination. DESIGN: Prospective study. SETTING: Nationwide sample from dialysis facilities. PATIENTS: 4791 patients receiving dialysis. MEASUREMENTS: Remainder plasma from a laboratory processing routine monthly tests was used to measure qualitative and semiquantitative antibodies to the receptor-binding domain (RBD) of SARS-CoV-2...
March 2022: Annals of Internal Medicine
https://read.qxmd.com/read/34850987/epitaxial-ferroelectric-hf-0-5-zr-0-5-o-2-with-metallic-pyrochlore-oxide-electrodes
#39
Zimeng Zhang, Shang-Lin Hsu, Vladimir A Stoica, Aviram Bhalla-Levine, Hanjong Paik, Eric Parsonnet, Alexander Qualls, Jianjun Wang, Liang Xie, Mukesh Kumari, Sujit Das, Zhinan Leng, Martin McBriarty, Roger Proksch, Alexei Gruverman, Darrell G Schlom, Long-Qing Chen, Sayeef Salahuddin, Lane W Martin, Ramamoorthy Ramesh
No abstract text is available yet for this article.
December 2021: Advanced Materials
https://read.qxmd.com/read/34671782/sars-cov-2-vaccine-antibody-response-and-breakthrough-infection-in-dialysis
#40
Shuchi Anand, Maria E Montez-Rath, Jialin Han, Pablo Garcia, LinaCel Cadden, Patti Hunsader, Curt Morgan, Russell Kerschmann, Paul Beyer, Mary Dittrich, Geoffrey A Block, Glenn M Chertow, Julie Parsonnet
BACKGROUND: Patients receiving dialysis are a sentinel population for groups at high risk for death and disability from COVID-19. Understanding correlates of protection post-vaccination can inform immunization and mitigation strategies. METHODS: Monthly since January 2021, we tested plasma from 4791 patients receiving dialysis for antibodies to the receptor-binding domain (RBD) of SARS-CoV-2 using a high-throughput assay. We qualitatively assessed the proportion without a detectable RBD response and among those with a response, semiquantitative median IgG index values...
October 14, 2021: medRxiv
keyword
keyword
165962
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.